Using Human Stool to Treat C. difficile is Safe, Effective


A novel therapy that uses donated human stool to treat the deadly and contagious Clostridium difficile infection is safe and highly effective, according to a Henry Ford Hospital study.

Researchers found that 43 of 49 patients recovered swiftly after treatment and had no adverse complications from C. difficile three months later. Treatment is performed either through a nasogastric tube or colonscopy on an outpatient or inpatient basis.

Mayur Ramesh, MD, a Henry Ford infectious diseases physician and senior author of the study, says the treatment, while appearing unconventional, has striking results.

More than 90 percent of the patients in our study were cured of their C. diff infection, says Ramesh. This treatment is a viable option for patients who are not responding to conventional treatment and who want to avoid surgery.

The study was presented last week at the IDWeek meeting in San Diego.

In their study, researchers evaluated 49 patients who contracted Clostridium difficile. Symptoms include water diarrhea, fever, loss of appetite, nausea and abdominal pain and tenderness. C. difficile occurs in patients taking antibiotics, and can spread from person-to-person contact or from touching contaminated equipment and objects like door knobs.

Patients with a C. difficile infection are typically treated with the antibiotics metronidazole or vancomycin. However, surgery could be required to remove the infected part of the intestines. In its study, Henry Ford treated patients between May 2010 and June 2012 with a therapy called intestinal microbiota transplantation (IMT), using donated stool from a healthy family member.

Ramesh says the healthy stool, when mixed with warm tap water and administered, helps to re-establish the normal intestinal flora in the patients gastrointestinal tract. Intestinal flora is healthy bacteria that stimulates the immune system and aids the digestion and absorption of food.

Patients who receive treatment through a nasogastric tube dont taste or smell the stool mixture as its administered, Ramesh says. Patients often resume their diet within a couple hours and are feeling better within 24 hours.

Of the 49 patients, 43 fully recovered, four died of causes unrelated to C. difficile, one had intestinal surgery and one had no improvement.

Source: Henry Ford Health System

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Related Content